Nutex Health (NASDAQ:NUTX) Earns Buy Rating from Analysts at Lake Street Capital

Equities researchers at Lake Street Capital initiated coverage on shares of Nutex Health (NASDAQ:NUTX) in a note issued to investors on Tuesday. The brokerage set a “buy” rating and a $235.00 price target on the stock. Lake Street Capital’s price target would indicate a potential upside of 83.57% from the company’s current price.

Several other equities research analysts have also recently commented on the stock. Wall Street Zen raised shares of Nutex Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Weiss Ratings raised shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, May 4th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $220.00.

Nutex Health Trading Down 0.8%

Shares of NASDAQ NUTX opened at $128.02 on Tuesday. The company’s fifty day moving average is $112.80 and its 200-day moving average is $127.82. The stock has a market cap of $880.78 million, a price-to-earnings ratio of 9.89 and a beta of 0.26. Nutex Health has a twelve month low of $77.21 and a twelve month high of $193.07. The company has a quick ratio of 3.12, a current ratio of 3.14 and a debt-to-equity ratio of 0.66.

Nutex Health (NASDAQ:NUTX) last announced its quarterly earnings results on Thursday, April 30th. The company reported $6.52 earnings per share for the quarter, topping analysts’ consensus estimates of $3.99 by $2.53. The company had revenue of $216.49 million for the quarter, compared to analysts’ expectations of $227.80 million. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the company. Deutsche Bank AG increased its stake in shares of Nutex Health by 3.9% during the 4th quarter. Deutsche Bank AG now owns 2,633 shares of the company’s stock worth $433,000 after purchasing an additional 98 shares during the last quarter. Russell Investments Group Ltd. increased its stake in shares of Nutex Health by 1.4% during the 4th quarter. Russell Investments Group Ltd. now owns 8,706 shares of the company’s stock worth $1,433,000 after purchasing an additional 116 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al increased its stake in shares of Nutex Health by 3.7% during the 4th quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 5,600 shares of the company’s stock worth $922,000 after purchasing an additional 200 shares during the last quarter. Islay Capital Management LLC acquired a new position in shares of Nutex Health during the 4th quarter worth about $34,000. Finally, First Trust Advisors LP increased its stake in shares of Nutex Health by 2.4% during the 4th quarter. First Trust Advisors LP now owns 11,461 shares of the company’s stock worth $1,887,000 after purchasing an additional 272 shares during the last quarter. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.